The report from the University of Toronto is welcome news following all the adverse -- even hysterical -- publicity on the risks that hormone therapy may have on breast cancer. This news will be particularly important to the many women who have family histories riddled with breast cancer and who carry the BRCA1 mutation. These women often undergo preemptive surgery for ovarian cancer prophylaxsis (oophorectomy) and/or bilateral mastectomy to avoid becoming yet another breast cancer statistic in their families.
A study reported in the March 25, 2010 New England Journal of Medicine "concludes that the risk of fracture of the subtrochanteric or diaphyseal femur associated with bisphosphonate use is very low, even in women with osteoporosis who received bisphosphonates for up to 10 years.
Given the limitation of a small number of events and wide confidence intervals, these studies did not show a significant increase in the risk of subtrochanteric or diaphyseal fracture with 3 to 4 years of use of alendronate or zoledronic acid or up to 10 years of alendronate use, the New England Journal of Medicine (NEJM) study said.
This press release and report were released
on Feb., 16, 2010. Dr. James A. Simon, director of this web site, is a
past president of the North American Menopause Society
Based on the best available evidence, “Estrogen and progestogen use in postmenopausal women: 2010 position statement of The North American Menopause Society” has just been released. Each section of the
previous paper was reviewed by an Advisory Panel of seventeen clinicians and
researchers expert in this area of women’s health using new studies and
findings. The paper was then approved by the NAMS Board of Trustees.
Dr. James A. Simon,
medical director of www.menopausewise.com wanted to be sure
his readers noted this press release and article. The press release is
from the Journal of Women's Health. At the end of the press release is a
link to the article.Here is the release:
Vibrance Associates is happy to welcome the Women's Health Foundation (WHF), a not-for-profit organization championing pelvic health and wellness for women of all ages through research, community and educational initiatives, including the Total Control® program, as a content sharer and provider to our sites and forums. It adds to our abilities to address this field. The WHF joins with our Pelvic Floor information providers, which include physical therapist provider, Amy Stein, MPT, BCB-PMD,
NEW POSITION PAPER: Here Is the NAMS 2010 Position Paper on Estrogen and progestogen use in postmenopausal women. Click here to read the report in its entireity.
